OBJECTIVES: To investigate the relationship between patient experience assessed through surveys of random samples of practice populations and intermediate outcome targets in those patients with diabetes, collected in the Quality and Outcomes Framework pay-for-performance scheme. DESIGN: Cross-sectional study. SETTING: The East Midlands region of England. PARTICIPANTS: Six hundred and twenty-nine general practices. MAIN OUTCOME MEASURES: Logistic regression models were used to assess whether practice-level reports of patient experience of access and consultations were associated with achievement of treatment targets (HbA1c of 7.5% and 10% or lower, BP 145/85 mmHg or lower, and cholesterol 5 mmol/L or lower) in people with diabetes. Survey respondent characteristics (ethnicity, age, sex) and practice size, deprivation, and prevalence of diabetes and obesity were also assessed within the models. RESULTS: Patient experience of practice populations explained little of the variation in diabetes treatment targets. In the practice survey, the proportion of respondents who had seen a nurse in the last 6 months was associated with increased likelihood of achieving HbA1c of 7.5%, and being involved in decision-making or having tests and treatment explained were associated with achievement of HbA1c of 10% or less, cholesterol of 5 mmol/L or less, and BP of 145/85 or less. CONCLUSIONS: Although patient experience at practice level should be included in monitoring outcomes, it should not replace monitoring clinical outcomes in diabetes. A mix of clinical and patient experience measures will have to be used to monitor outcomes in general practice.
OBJECTIVES: To investigate the relationship between patient experience assessed through surveys of random samples of practice populations and intermediate outcome targets in those patients with diabetes, collected in the Quality and Outcomes Framework pay-for-performance scheme. DESIGN: Cross-sectional study. SETTING: The East Midlands region of England. PARTICIPANTS: Six hundred and twenty-nine general practices. MAIN OUTCOME MEASURES: Logistic regression models were used to assess whether practice-level reports of patient experience of access and consultations were associated with achievement of treatment targets (HbA1c of 7.5% and 10% or lower, BP 145/85 mmHg or lower, and cholesterol 5 mmol/L or lower) in people with diabetes. Survey respondent characteristics (ethnicity, age, sex) and practice size, deprivation, and prevalence of diabetes and obesity were also assessed within the models. RESULTS:Patient experience of practice populations explained little of the variation in diabetes treatment targets. In the practice survey, the proportion of respondents who had seen a nurse in the last 6 months was associated with increased likelihood of achieving HbA1c of 7.5%, and being involved in decision-making or having tests and treatment explained were associated with achievement of HbA1c of 10% or less, cholesterol of 5 mmol/L or less, and BP of 145/85 or less. CONCLUSIONS: Although patient experience at practice level should be included in monitoring outcomes, it should not replace monitoring clinical outcomes in diabetes. A mix of clinical and patient experience measures will have to be used to monitor outcomes in general practice.
Authors: Stephen M Auerbach; John N Clore; Donald J Kiesler; Tamara Orr; Phillip O Pegg; Ben G Quick; Christopher Wagner Journal: J Behav Med Date: 2002-02
Authors: Charlotte Bebb; Carol Coupland; Jane Stewart; Denise Kendrick; Richard Madeley; Nigel Sturrock; Richard Burden Journal: Fam Pract Date: 2007-10-25 Impact factor: 2.267
Authors: Pamela A Ohman-Strickland; A John Orzano; Shawna V Hudson; Leif I Solberg; Barbara DiCiccio-Bloom; Dena O'Malley; Alfred F Tallia; Bijal A Balasubramanian; Benjamin F Crabtree Journal: Ann Fam Med Date: 2008 Jan-Feb Impact factor: 5.166